What's new

Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Date of authorisation: 12/12/2024, Status: Authorised

Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Date of authorisation: 12/12/2024, Status: Authorised

Mar 6, 2025 - 14:28
 0
Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Date of authorisation: 12/12/2024, Status: Authorised
Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Date of authorisation: 12/12/2024, Status: Authorised
Read More

Tags:

Previous Article

Denali's ALS drug fails to redeem itself, missing key biomarker in trial extension

Next Article

Space-based capabilities are critical to enabling a missile shield for America

Related Posts

Herbal medicinal product: Boldi foliumArray, C: ongoing call for scientific data

Herbal medicinal product: Boldi foliumArray, C: ongoing...

Feb 11, 2025  0

Agenda - ACT EU workshop on ICH E6 (R3)

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0